| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Feb―28 |
Modifications to prostate cancer diagnosis following COVID-19 and following models |
Miroslav Stojadinovic, Milorad Stojadinovic, Slobodan Jankovic |
| 2 |
[GO] |
2024―Mar―14 |
Prioritization and resource allocation in the context of the COVID-19 pandemic. Recommendations for colorectal and pancreatic cancer in Germany |
Celine Lugnier, Sabine Sommerlatte, Ulrike Attenberger, Ambros J. Beer, Martin Bentz, Stefan R. Benz, et al. (+34) Thomas Birkner, Jens Büntzel, Matthias Ebert, Peter Fasching, Wolfgang Fischbach, Emmanouil Fokas, Birgit Fricke, Helene Hense, Erich Grohmann, Ralf-Dieter Hofheinz, Dietrich Hüppe, Stefan Huster, Patrick Jahn, Monika Klinkhammer-Schalke, Wolfgang Knauf, Anna-Lena Kraeft, Bernd Oliver Maier, Georg Marckmann, Günter Niegisch, Lutz Otto, Uwe Pelzer, Pompiliu Piso, Henning Rosenau, Jochen Schmitt, Olaf Schoffer, Jalid Sehouli, Andrea Tannapfel, Ulrich Wedding, Simone Wesselmann, Eva C. Winkler, Tanja Zimmermann, Bernhard Wörmann, Anke Reinacher-Schick, Jan Schildmann |
| 3 |
[GO] |
2023―Nov―15 |
COVID-19 in patients with active - higher inflammatory activity predicts poor outcome. |
Maria Madeleine Rüthrich, Yascha Khodamoradi, Julia Lanznaster, Melanie Stecher, Lukas Tometten, Florian Voit, et al. (+9) Carolin E.M. Koll, Stefan Borgmann, Jörg Janne Vehreschild, Björn-Erik Ole Jensen, Frank Hanses, Clemens Giessen-Jung, Kai Wille, Marie von Lilienfeld-Toal, Gernot Beutel |
| 4 |
[GO] |
2023―Feb―24 |
High in-hospital mortality in SARS-CoV-2 infected patients with active cancer disease during Omicron phase of the pandemic - Insights from the CORONA Germany Study |
Francis Maren Konermann, Nele Gessler, Peter Wohlmuth, Jürgen Behr, Johannes Feldhege, Christian Glöckner, et al. (+9) Melanie A Gunawardene, Klaus R. Herrlinger, Thomas Hölting, Ulrich-Frank Pape, Niels Reinmuth, Axel Stang, Sara Sheikhzadeh, Dirk Arnold, Claas Wesseler |
| 5 |
[GO] |
2022―Jul―18 |
Oncologic rehabilitation in the COVID-19 pandemic: the situation in clinics |
Oliver Rick, Wilfried Hoffmann, Monika Anna Steimann |
| 6 |
[GO] |
2021―Nov―01 |
Low Serological Prevalence of SARS-CoV-2 Antibodies in Cancer Patients at a German University Oncology Center |
Oliver Overheu, Daniel Robert Quast, Wolfgang E. Schmidt, Türkan Sakinç-Güler, Anke Reinacher-Schick |
| 7 |
[GO] |
2021―May―03 |
Maintaining an Adult Hematology/Oncology Service at a Tertiary Care Center during the SARS-CoV-2 Pandemic: An Eight-Week-Experience with a Newly Implemented Procedural Plan |
Philipp G. Hemmati, Dorothea Fischer, Frank Breywisch, Sabine Wohlfarth, Matthias Kramer, Matthias Paland, et al. (+4) Lukas Tometten, Harun Badakhshi, Gerald Ripberger, Georg Maschmeyer |
| 8 |
[GO] |
2020―Dec―17 |
Decreased Incidence of Oncology Admissions in 75 Helios Hospitals in Germany during the COVID-19 Pandemic |
Peter Reichardt, Andreas Bollmann, Sven Hohenstein, Bertram Glass, Michael Untch, Annette Reichardt, et al. (+2) Daniel Amrein, Ralf Kuhlen |
| 9 |
[GO] |
2020―May―14 |
Community-Acquired Respiratory Viruses in Oncology: Lessons to Be Learnt from the SARS-CoV-2 Pandemic |
Marie von Lilienfeld-Toal |
| 10 |
[GO] |
2020―May―07 |
Implications of SARS-CoV-2 Infection and COVID-19 Crisis on Clinical Cancer Care: Report of the University Cancer Center Hamburg |
Katja C. Weisel, Andrea Morgner-Miehlke, Cordula Petersen, Walter Fiedler, Andreas Block, Philippe Schafhausen, et al. (+2) Johannes K. Knobloch, Carsten Bokemeyer |
|
